LUNIT INC
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Lunit AI Enhances Precision in Predicting Outcomes for HER2-Targeted Therapy in Metastatic Colorectal Cancer - new study published in JCO Precision Oncology 2025-01-23 22:00
New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images 2024-12-12 22:08
Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW 2024-12-09 22:00
Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care 2024-12-05 22:07
Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment 2024-12-02 22:00
Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging 2024-11-27 22:00
Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts 2024-11-25 22:00
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC 2024-11-18 22:00
Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network 2024-11-13 22:00
Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024 2024-11-08 22:00
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance 2024-10-23 21:00
Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024 2024-09-10 21:00
Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing 2024-09-09 21:00
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR 2024-09-03 21:00
Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study 2024-08-06 21:00
Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program 2024-07-22 21:00
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response 2024-05-24 22:07
Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care 2024-05-22 21:00
Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite 2024-05-20 21:00
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals 2024-04-08 21:00
1 2 3 4 5 6